Anna Potulska‐Chromik

Swallowing disorders in Parkinson's disease

Anna Potulska‐Chromik, Andrzej Friedman, Leszek Królicki et al. · Parkinsonism & Related Disorders · 2003 · 229 citations

Phoniatrics, Motor Dysfunction, Parkinson Disease +8

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban et al. · The Lancet Neurology · 2019 · 216 citations · Full text

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 169 citations · Full text

Late-onset Pompe Disease, Autoimmune Disease, Clinical Infectious Disease +3

Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.

Jarosław Sławek, Andrzej Friedman, Anna Potulska‐Chromik et al. · CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche) · 2007 · 93 citations

Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease

Dorota Hoffman‐Zacharska, Dariusz Koziorowski, Owen A. Ross et al. · Parkinsonism & Related Disorders · 2013 · 84 citations · Full text

Neurodegenerative Diseases, Neurobiology Of Disease, Biochemistry +11